NextGenBioPest at AMCA 2026!

From March 23rd to 27th, 2026, our partner Preagon Biotech attended the 92nd Annual Meeting of the American Mosquito Control Association (AMCA) in Portland, Oregon, USA. The company used the occasion to present its selective juvenoids to industry partners, taking part in bilateral meetings with mosquito-control companies at a gathering of more than 1,000 researchers, vector control professionals and industry representatives.

Meeting website: https://amca2026.eventscribe.net/index.asp

A Global Meeting Point for Vector Control

The AMCA annual meeting is one of the largest events dedicated to mosquito control and the management of insect-borne diseases. It brings together scientists, public health professionals, product developers and the companies that supply tools to mosquito-control programmes. For a technology company developing selective insecticides, it is an ideal setting to meet potential partners and users face to face.

Why Selective Juvenoids Matter

Selective juvenoids are compounds that act on the juvenile hormone pathway, which regulates insect development. Because they can be designed to target specific pests, they offer an alternative to broad-spectrum insecticides, which can also affect pollinators, natural enemies and other non-target organisms.

Although the AMCA meeting focuses on mosquito control, the underlying principle is the same one that drives NextGenBioPest in agriculture: effective pest management does not have to come at the expense of biodiversity and the environment. Technologies that prove their value in one application field often open doors in others, and showing the potential of selective juvenoids to the vector control community helps demonstrate the versatility of the approach.

From Presentations to Partnerships

The most important outcome of the visit was direct dialogue. Through bilateral meetings with mosquito-control companies, Preagon Biotech was able to present its technology in detail, hear what industry partners need from new products, and explore possibilities for collaboration. This type of exchange is essential for turning promising science into products that can be tested, registered and eventually used in the field.

For NextGenBioPest, it also shows how consortium partners are extending the reach of project-related technologies beyond Europe and into international markets.